Ignite Creation Date:
2024-05-06 @ 7:07 PM
Last Modification Date:
2024-10-26 @ 3:01 PM
Study NCT ID:
NCT05904093
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2024-07-15
First Post:
2023-06-13
Brief Title:
Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in Subjects With Stable Sickle Cell Disease
Sponsor:
National Heart Lung and Blood Institute NHLBI
Organization:
National Institutes of Health Clinical Center CC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-07-18
Start Date Type:
ESTIMATED
Primary Completion Date:
2024-08-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-05-14
Completion Date Type:
ESTIMATED
First Submit Date:
2023-06-13
First Submit QC Date:
June 13 2023
Study First Post Date:
2023-06-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-23
Last Update Post Date:
2024-07-15
Last Update Post Date Type:
ESTIMATED